Moderna
MRNA
$102.00
Share price
-1.39%
Change (1 day)
-28.49%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
EPS for Moderna (MRNA)
EPS in 2023 (TTM): -$9.14
According to Moderna 's latest financial reports the company's current EPS (TTM) is -$9.14. In 2022 the company made an earnings per share (EPS) of $21.12 a decrease over its 2021 EPS that were of $30.28.
EPS history for Moderna from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$9.14 | -143.28% |
| 2022 | $21.12 | -30.25% |
| 2021 | $30.28 | -1660.82% |
| 2020 | -$1.94 | 25.16% |
| 2019 | -$1.55 | 37.04% |
| 2018 | -$1.13 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -254.11% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -140.92% | 🇨🇭 Switzerland |
 Merck MRK | $1.82 | -119.93% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -$1.69 | -81.51% | 🇺🇸 USA |
 Athersys ATHX | -$3.03 | -66.85% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$4.11 | -55.03% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | -$1.70 | -81.40% | 🇺🇸 USA |